When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CAPR - Capricor Therapeutics -2% on DMD trial halt
Capricor Therapeutics Inc.
Capricor Therapeutics (NASDAQ:CAPR) announces putting its Duchenne muscular dystrophy trial for lead drug CAP-1002 on hold after a safety review following a severe allergic reaction during infusion.
More news on: Capricor Therapeutics, Inc., Healthcare stocks news, Stocks on the move,